Elizabeth L. Eby

998 total citations
31 papers, 739 citations indexed

About

Elizabeth L. Eby is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Family Practice. According to data from OpenAlex, Elizabeth L. Eby has authored 31 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Family Practice. Recurrent topics in Elizabeth L. Eby's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (15 papers) and Medication Adherence and Compliance (7 papers). Elizabeth L. Eby is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (15 papers) and Medication Adherence and Compliance (7 papers). Elizabeth L. Eby collaborates with scholars based in United States, United Kingdom and Switzerland. Elizabeth L. Eby's co-authors include John D. Piette, Michele Heisler, A. Mark Fendrick, Kenneth M. Langa, Mohammed U. Kabeto, M. Rizwan Sohail, Arnold J. Greenspon, Allison Petrilla, Laura Wright and Candace Gunnarsson and has published in prestigious journals such as Journal of the American College of Cardiology, Diabetes and Medical Care.

In The Last Decade

Elizabeth L. Eby

31 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth L. Eby United States 15 217 207 200 176 146 31 739
Claire Buckley Ireland 14 42 0.2× 108 0.5× 257 1.3× 53 0.3× 116 0.8× 68 669
Ronak S. Kanani Canada 4 109 0.5× 83 0.4× 35 0.2× 191 1.1× 61 0.4× 6 594
David J. Heller United States 12 153 0.7× 153 0.7× 64 0.3× 26 0.1× 55 0.4× 26 519
Adriana Dornelles United States 13 138 0.6× 48 0.2× 51 0.3× 118 0.7× 82 0.6× 27 492
Georgios Gkountouras United Kingdom 10 34 0.2× 107 0.5× 123 0.6× 67 0.4× 78 0.5× 15 473
Gualberto Gussoni Italy 14 174 0.8× 58 0.3× 65 0.3× 22 0.1× 91 0.6× 42 530
Osei Sarfo‐Kantanka Ghana 18 217 1.0× 45 0.2× 318 1.6× 37 0.2× 316 2.2× 39 897
James Kayima Uganda 14 377 1.7× 48 0.2× 106 0.5× 37 0.2× 251 1.7× 42 901
Andrew Tonkin Australia 10 139 0.6× 96 0.5× 21 0.1× 65 0.4× 40 0.3× 19 378
Ira S. Nash United States 14 167 0.8× 78 0.4× 28 0.1× 40 0.2× 44 0.3× 32 645

Countries citing papers authored by Elizabeth L. Eby

Since Specialization
Citations

This map shows the geographic impact of Elizabeth L. Eby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth L. Eby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth L. Eby more than expected).

Fields of papers citing papers by Elizabeth L. Eby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth L. Eby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth L. Eby. The network helps show where Elizabeth L. Eby may publish in the future.

Co-authorship network of co-authors of Elizabeth L. Eby

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth L. Eby. A scholar is included among the top collaborators of Elizabeth L. Eby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth L. Eby. Elizabeth L. Eby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hankosky, Emily R., Michelle L. Katz, Ludi Fan, et al.. (2023). Predictors of insulin pump initiation among people with type 2 diabetes from a US claims database using machine learning. Current Medical Research and Opinion. 39(6). 843–853. 5 indexed citations
2.
3.
Heidenreich, Sebastian, et al.. (2022). POSB372 Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Diabetes Patients in the UK and US. Value in Health. 25(1). S233–S233. 1 indexed citations
4.
Heidenreich, Sebastian, et al.. (2022). Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes. Patient. 16(2). 127–138. 8 indexed citations
5.
Katz, Michelle L., et al.. (2022). POSC390 Predictors of Insulin Pump Initiation Among People with Type 2 Diabetes from a US Claims Database Using Machine Learning. Value in Health. 25(1). S265–S265. 1 indexed citations
6.
Perez‐Nieves, Magaly, et al.. (2022). 75-LB: Use of Continuous Glucose Monitoring (CGM) and Its Association with Economic Outcomes in the Real-World Setting. Diabetes. 71(Supplement_1). 1 indexed citations
8.
Steenkamp, Devin, et al.. (2021). Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem. Journal of Diabetes Science and Technology. 16(4). 995–1002. 23 indexed citations
9.
Eby, Elizabeth L., et al.. (2020). Economic impact of cardiac implantable electronic device infections: cost analysis at one year in a large U.S. health insurer. Journal of Medical Economics. 23(7). 698–705. 20 indexed citations
10.
Eby, Elizabeth L., et al.. (2017). ANTIBACTERIAL ENVELOPE IS ASSOCIATED WITH MEDICAL COST SAVINGS IN PATIENTS AT HIGH RISK FOR CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTION. Journal of the American College of Cardiology. 69(11). 382–382. 1 indexed citations
11.
Eby, Elizabeth L., et al.. (2015). Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States. Clinical Therapeutics. 37(10). 2297–2308.e1. 7 indexed citations
12.
Lage, Maureen J., et al.. (2015). Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes. Clinical Interventions in Aging. 10. 991–991. 2 indexed citations
13.
Perez‐Nieves, Magaly, Dingfeng Jiang, & Elizabeth L. Eby. (2015). Incidence, prevalence, and trend analysis of the use of insulin delivery systems in the United States (2005 to 2011). Current Medical Research and Opinion. 31(5). 891–899. 15 indexed citations
14.
Eby, Elizabeth L., Anthony J. Zagar, Ping Wang, et al.. (2014). Healthcare Costs and Adherence Associated with Human Regular U-500 Versus High-Dose U-100 Insulin in Patients with Diabets. Endocrine Practice. 20(7). 663–670. 24 indexed citations
15.
Criswell, John, et al.. (2014). Economic impact of converting from 10-mL insulin vials to 3-mL vials and pens in a hospital setting. American Journal of Health-System Pharmacy. 71(17). 1485–1489. 2 indexed citations
16.
Eby, Elizabeth L., Ping Wang, Bradley Curtis, et al.. (2013). Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis. Journal of Medical Economics. 16(4). 529–538. 26 indexed citations
17.
Eby, Elizabeth L., Kristina S. Boye, & Maureen J. Lage. (2013). The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study. Journal of Medical Economics. 16(10). 1231–1237. 6 indexed citations
18.
Kim, Catherine, Elizabeth L. Eby, & John D. Piette. (2005). Is education associated with mortality for breast cancer and cardiovascular disease among black and white women?. Gender Medicine. 2(1). 13–18. 16 indexed citations
19.
Heisler, Michele, Kenneth M. Langa, Elizabeth L. Eby, et al.. (2004). The Health Effects of Restricting Prescription Medication Use Because of Cost. Medical Care. 42(7). 626–634. 250 indexed citations
20.
Puder, Karoline S., et al.. (2003). Folic Acid Awareness in Michigan, 1996–1999. Obstetrics and Gynecology. 102(5, Part 1). 1046–1050. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026